PLURALINK

Serial Number 98677579
686

Registration Progress

Application Filed
Aug 1, 2024
Under Examination
Approved for Publication
Jun 17, 2025
Published for Opposition
Jun 17, 2025
Registered

Trademark Image

PLURALINK

Basic Information

Serial Number
98677579
Filing Date
August 1, 2024
Published for Opposition
June 17, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 17, 2025
Application
Pending
Classes
005 042 045

Rights Holder

The Board of Regents of the University of Texas System

14
Address
210 West 7th Street
Austin, TX 78701

Ownership History

The Board of Regents of the University of Texas System

Original Applicant
14
Austin, TX

The Board of Regents of the University of Texas System

Owner at Publication
14
Austin, TX

Legal Representation

Attorney
A. Reagan Fibbe

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description Documents
Jun 17, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 17, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 11, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 13, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 12, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 12, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 12, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 10, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 10, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 10, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 7, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 1, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for cell therapy; cells and cell lines for medical or clinical use; cellular pharmaceutical preparations for use in oncology; natural killer (NK) cell preparations for clinical use, medical use, and laboratory use; pharmaceutical preparations in the nature of cells and viral systems comprised of viral vectors used to deliver modified genetic material into other cells for medical purposes; kits comprised of cell-derived preparations, namely, natural killer cell and other immune cell-derived preparations for clinical, medicinal, and therapeutic use
Class 042
Medical and scientific research; cell therapy research and development; scientific and technological services, namely, research, analysis and testing in the field of oncology, cell therapy, and immuno-oncology
Class 045
Licensing of intellectual property

Classification

International Classes
005 042 045